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Introduction {#sec1}
============

Non-cancerous cells and matricellular molecules within the tumor, collectively defined as the tumor microenvironment ([@bib2], [@bib3], [@bib20]), participate in many hallmarks of cancer ([@bib15]). Cancer-associated fibroblasts (CAFs) can provide chemical and physical cues that favor tumor aggressiveness and dissemination ([@bib21], [@bib22]). CAF-dependent matrix remodeling can lead to the generation of tracks through the extracellular matrix (ECM) that enable subsequent cancer cell invasion ([@bib13]). As a result of increased deposition and remodeling of the ECM by CAFs, most solid tumors are characterized by elevated cellular and tissue tension, and enhanced stiffness ([@bib7], [@bib25], [@bib32]). These altered physical properties can promote malignancy by enhancing cancer cell growth, survival, and migration ([@bib7]). CAFs also produce soluble factors that can promote tumorigenesis ([@bib30]). Thus, targeting CAFs represents a possibility for therapeutic intervention.

Changes in the actin cytoskeleton, including increased actin stress fibers, αSMA expression, and stronger focal adhesions, is a feature of CAFs ([@bib4], [@bib21], [@bib30], [@bib35], [@bib39]). Increased actomyosin contractility also leads to activation of the transcriptional regulator YAP1 that is critical for the CAF phenotype ([@bib4]). Much less is known about alterations to other cytoskeletal networks. Septins are a large conserved family of GTP-binding proteins that participate in cell division, cytoskeletal organization, vesicular transport, cell polarity, and membrane remodeling ([@bib28], [@bib38]). SEPT2, SEPT6, and SEPT7 can assemble into hetero-oligomeric complexes and higher-order structures, including filaments and rings ([@bib37]). The adaptor protein Anillin (ANLN) controls actin-septin coordination during cytokinesis, whereas unknown factors mediate this process during interphase ([@bib24]). BORG family proteins, such as Cdc42EP3 and Cdc42EP5, are potential candidates to fulfill this role. These proteins bind active Cdc42 ([@bib1], [@bib18]) and SEPT2, 6, and 7 ([@bib19]). Overexpression of Cdc42EP3 in fibroblasts can induce the formation of pseudopodia and F-actin-containing structures ([@bib17]), while Cdc42EP5 can regulate septin organization within the cell ([@bib19], [@bib36]). However, the role of BORG proteins in the tumor microenvironment is not well understood. Here, we examine the role of Cdc42EP3/BORG2 and septins in regulating CAF emergence, maintenance, and functions linked to essential rearrangements in the actin and septin network.

Results {#sec2}
=======

Identification of Cdc42EP3 as a Regulator of CAF Functions {#sec2.1}
----------------------------------------------------------

To learn about the role of the cytoskeleton in CAFs, we compared its organization in normal fibroblasts (NFs) and CAFs from the MMTV-PyMT mammary tumor model ([@bib4]). In NFs, F-actin was mainly at the cell cortex and only small focal adhesions were present ([Figure 1](#fig1){ref-type="fig"}A; quantification in [Figure 1](#fig1){ref-type="fig"}B). In contrast, CAFs had enhanced F-actin stress fibers containing active pS19 myosin light chain 2 (MLC2; phosphorylation on S19 is the major positive regulatory mechanism of myosin activity in non-muscle cells) and abundant paxillin-positive focal adhesions ([Figure 1](#fig1){ref-type="fig"}A; quantification in [Figure 1](#fig1){ref-type="fig"}B). We confirmed the elevated levels of pS19-MLC2 in CAFs by western blotting ([Figure 1](#fig1){ref-type="fig"}C) and also observed elevated levels of active Src-family kinases and increased phosphorylation of paxillin on the FAK and Src-family kinase site, Y118 ([Figure 1](#fig1){ref-type="fig"}C) ([@bib5]).

We selected 21 cytoskeletal components that are highly expressed in CAFs compared to NFs based on microarray data ([@bib4]) and depleted them in CAFs. Following small interfering RNA (siRNA) transfection, the ability of CAF\#1 to contract collagen gels and promote the invasion of breast cancer cells in "organotypic" assays was determined. Invasion assays were also performed using CAF\#2. [Figure 1](#fig1){ref-type="fig"}D shows the effect of gene depletion in each assay, together with a combined metric of "CAF functionality" derived by averaging the individual assay results. Depletion of *Cdc42ep3* reduced CAF function to a similar extent as targeting *Rock1* ([Figure 1](#fig1){ref-type="fig"}D), a known regulator of CAF function that was used as a positive control ([@bib13]). Depletion of Cdc42EP3 with three independent siRNA led to reduced ECM remodeling by CAFs ([Figures 1](#fig1){ref-type="fig"}E and 1F, confirmed in CAF\#2; [Figure S1](#mmc1){ref-type="supplementary-material"}A). There was also a significant reduction in the cancer cell invasion promoting abilities of CAF\#1 and CAF\#2 after Cdc42EP3 depletion ([Figures 1](#fig1){ref-type="fig"}G and [S1](#mmc1){ref-type="supplementary-material"}A). Similar results were obtained in human-patient-derived CAFs ([Figures S1](#mmc1){ref-type="supplementary-material"}B--S1D). Depletion of Cdc42EP3 did not affect the expression of the CAF markers αSMA and FAP ([Figure S1](#mmc1){ref-type="supplementary-material"}E).

*Cdc42ep3* encodes a protein of the BORG family of Cdc42 effectors ([@bib18]). We confirmed that Cdc42EP3 levels were upregulated in three different CAFs when compared to NFs ([Figure 1](#fig1){ref-type="fig"}H), whereas levels of other BORG members were unchanged ([Figures 1](#fig1){ref-type="fig"}H and [S1](#mmc1){ref-type="supplementary-material"}F). Analysis of expression levels of BORG genes in patient datasets ([@bib11], [@bib22]) revealed that *CDC42EP3* was consistently upregulated in the stromal compartment of human breast carcinoma compared to normal tissue samples ([Figure S1](#mmc1){ref-type="supplementary-material"}G). These analyses led us to focus on Cdc42EP3 in CAFs.

Altered Septin Networks Are a Feature of CAFs {#sec2.2}
---------------------------------------------

BORG proteins can regulate the actin and septin cytoskeleton ([@bib18], [@bib19]). We therefore investigated the septin network in NFs and CAFs. SEPT2 and SEPT7 formed more extensive networks in CAFs ([Figure 2](#fig2){ref-type="fig"}A; quantification in [Figure S2](#mmc1){ref-type="supplementary-material"}A) that generally co-aligned with actin stress fibers ([Figure S2](#mmc1){ref-type="supplementary-material"}B). This was confirmed using a biochemical method based on fractionation of detergent insoluble cytoskeletal components ([@bib33]). In NFs the amount of actin present in the insoluble fraction was low ([Figures 2](#fig2){ref-type="fig"}B and [S2](#mmc1){ref-type="supplementary-material"}C). This increased greatly in all four CAFs examined. Importantly, there was a similar shift of both SEPT2 and SEPT7 into the insoluble fraction in CAF\#1--4 ([Figures 2](#fig2){ref-type="fig"}B and [S2](#mmc1){ref-type="supplementary-material"}C). Time-lapse imaging of CAFs revealed that SEPT2 was highly dynamic, with SEPT2 puncta moving on and off actin stress fibers ([Figure S2](#mmc1){ref-type="supplementary-material"}D; [Movie S1](#mmc2){ref-type="supplementary-material"}). In contrast, SEPT2 localization and dynamics did not show a clear relationship to actin in NFs ([Figure S2](#mmc1){ref-type="supplementary-material"}D; [Movie S2](#mmc3){ref-type="supplementary-material"}). This was reflected in the lower co-localization coefficient of the Lifeact and SEPT2-GFP probes in NFs ([Figures S2](#mmc1){ref-type="supplementary-material"}E and S2F demonstrate that GFP does not co-localize with F-actin). Structured illumination microscopy (SIM) revealed that SEPT2-GFP was present along actin stress fibers, but not always exactly coincident with them ([Figure 2](#fig2){ref-type="fig"}C, white arrows). Furthermore, there were wavy filaments that occasionally connected nearby stress fibers ([Figure 2](#fig2){ref-type="fig"}C, green arrows). We hypothesized that Cdc42EP3 may coordinate the actin and septin networks. Endogenous Cdc42EP3 partially co-localized with actin stress fibers in CAFs ([Figure 2](#fig2){ref-type="fig"}D). Further, SIM revealed that Cdc42EP3-GFP forms an intricate filamentous network in CAFs ([Figure 2](#fig2){ref-type="fig"}E). Similar to the SEPT2 network, the Cdc42EP3 network is clearly aligned with, but not exactly coincident with, F-actin ([Figure 2](#fig2){ref-type="fig"}E). It often formed filaments close to, or wrapped around, actin stress fibers ([Figure 2](#fig2){ref-type="fig"}E, white arrows), while other filaments presented a wavy pattern and did not co-align with F-actin ([Figure 2](#fig2){ref-type="fig"}E, yellow arrows). Time-lapse imaging showed that Cdc42EP3 moved both between and along stress fibers, in a manner similar to SEPT2 ([Movies S3](#mmc4){ref-type="supplementary-material"} and [S4](#mmc5){ref-type="supplementary-material"}). Triple labeling of F-actin, SEPT2-Cherry, and Cdc42EP3-GFP revealed that Cdc42EP3 co-localized with SEPT2 filaments ([Figure 2](#fig2){ref-type="fig"}F). These filaments exhibited a partial overlap with F-actin stress fibers ([Figure 2](#fig2){ref-type="fig"}F, white arrows), but also formed connections between actin fibers ([Figure 2](#fig2){ref-type="fig"}F, yellow arrows). Further, SIM imaging revealed that Cdc42EP3 could localize between F-actin fibers and SEPT2 filaments ([Figure 2](#fig2){ref-type="fig"}G). Together, these data suggest that Cdc42EP3 links the actin and septin networks.

Depletion of Cdc42EP3 in CAFs resulted in the loss of actin stress fibers and reduced pS19-MLC2 staining ([Figure 3](#fig3){ref-type="fig"}A; quantification in [Figure S3](#mmc1){ref-type="supplementary-material"}A). Moreover, the network of SEPT2 and SEPT7 fibers was also disrupted upon Cdc42EP3 depletion ([Figure 3](#fig3){ref-type="fig"}B; quantification in [Figure S3](#mmc1){ref-type="supplementary-material"}B, confirmed with two siRNA in [Figure S3](#mmc1){ref-type="supplementary-material"}C). Fractionation confirmed significant reductions in filamentous insoluble levels of F-actin, SEPT2, and SEPT7 in Cdc42EP3-depleted CAFs ([Figures 3](#fig3){ref-type="fig"}C and [S3](#mmc1){ref-type="supplementary-material"}D); the total levels of actin, SEPT2, and SEPT7 were unaltered ([Figure S3](#mmc1){ref-type="supplementary-material"}E). These changes were associated with significantly reduced CAF cellular stiffness ([Figure 3](#fig3){ref-type="fig"}D).

Gain-of-function experiments demonstrated that overexpression of Cdc42EP3 in NFs was sufficient to induce actin, SEPT2, and SEPT7 polymerization ([Figure 3](#fig3){ref-type="fig"}E). The ability of Cdc42EP3 to bind both septins ([@bib18], [@bib19]) and the data in [Figure S3](#mmc1){ref-type="supplementary-material"}I showing a direct interaction with F-actin suggest that it may act as a "molecular glue" linking the two networks. To explore this idea, we generated Cdc42EP3 mutants defective in interaction with septins, F-actin, or Cdc42 ([Figures S3](#mmc1){ref-type="supplementary-material"}F--S3H). We mutated key residues in the septin-binding BD3 domain (Cdc42EP3 GPS-AAA mutant \[[@bib18], [@bib19]\]) and the CRIB domain (Cdc42EP3 IS-AA mutant) ([Figure S3](#mmc1){ref-type="supplementary-material"}G). To generate a putative actin-binding defective mutant, we mutated the amino acids KLP in positions 139--141 ([Figure S3](#mmc1){ref-type="supplementary-material"}H). These residues are within a region of the protein with high homology to the actin bundling region of ANLN ([@bib10]) and the actin-binding head piece of villin ([@bib12]). Immunoprecipitation analyses indicated that the GPS mutant of Cdc42EP3 still interacted with actin but had reduced binding to SEPT2 ([Figure S3](#mmc1){ref-type="supplementary-material"}J). On the other hand, Cdc42EP3 KLP-AAA did not interact with actin but maintained the SEPT2 and SEPT7 binding abilities. Unfortunately, the CRIB domain mutant of Cdc42EP3 (Cdc42EP3 IS-AA) was also defective in interaction with actin; because it did not represent a specific loss of function, we excluded this mutant from further analysis.

We assessed the function of these Cdc42EP3 mutants in NFs, which have low Cdc42EP3 expression and relatively low F-actin and filamentous septin levels ([Figures 2](#fig2){ref-type="fig"}A and [S2](#mmc1){ref-type="supplementary-material"}B). Overexpression of wild-type Cdc42EP3 led to prominent SEPT2 and SEPT7 filaments ([Figure 3](#fig3){ref-type="fig"}F with quantification in [Figure 3](#fig3){ref-type="fig"}H) and actin stress fibers ([Figures 3](#fig3){ref-type="fig"}G and 3H). As previously observed in CAFs ([Figure 2](#fig2){ref-type="fig"}E), wild-type Cdc42EP3-GFP in NFs formed filamentous structures that co-aligned with septin filaments and actin fibers ([Figures 3](#fig3){ref-type="fig"}F and 3G, with quantification in [Figure 3](#fig3){ref-type="fig"}H). Neither the GPS nor KLP mutant of Cdc42EP3 could induce the formation of actin or septin fibers ([Figures 3](#fig3){ref-type="fig"}F--3H). Further, the localization of both mutants was largely diffuse. These results indicate that Cdc42EP3 needs to directly bind both F-actin and septins to drive both networks into a filamentous state.

The Septin Cytoskeleton Is Required for CAF Functions {#sec2.3}
-----------------------------------------------------

To test the role of septins in CAFs, we disrupted the septin network using siRNA-targeting SEPT2. Depletion of SEPT2 led to a loss of actomyosin stress fibers ([Figure 4](#fig4){ref-type="fig"}A) and fewer paxillin-containing focal adhesions ([Figure 4](#fig4){ref-type="fig"}B). This phenotype was very similar to that observed following Cdc42EP3 depletion or DIAPH1&3 depletion, which is known to block stress fiber formation ([@bib29]). Western blotting for pS19-MLC2, active Src-family kinases, and pY118-paxillin confirmed the altered state of the actomyosin cytoskeleton and focal adhesions ([Figure 4](#fig4){ref-type="fig"}C). Biochemical fractionation revealed that depletion of either SEPT2 or SEPT7 led to a significant reduction in the level of F-actin in CAFs ([Figure 4](#fig4){ref-type="fig"}D). These data establish the inter-relationship of these two networks in CAFs. Next, we investigated the functional importance of the septin network in CAFs. [Figure 4](#fig4){ref-type="fig"}E shows that depletion of SEPT2 or SEPT7 significantly reduced the ability of CAF\#1 to contract collagen-rich gels (confirmed in other CAFs in [Figure S4](#mmc1){ref-type="supplementary-material"}A). The requirement for both Cdc42EP3 and SEPT2 for effective ECM remodeling was confirmed by staining for the deposition of fibrillar fibronectin and quantification of DQ-collagen I proteolysis ([Figures S4](#mmc1){ref-type="supplementary-material"}B and S4C). [Figure 4](#fig4){ref-type="fig"}F further shows that the reduced ECM remodeling was associated with lower matrix stiffness. Moreover, the ability of CAFs to promote cancer cell invasion was reduced following SEPT2 or SEPT7 depletion ([Figure 4](#fig4){ref-type="fig"}G; confirmed in other CAFs in [Figure S4](#mmc1){ref-type="supplementary-material"}D).

Next, we sought to test the role of Cdc42EP3 and septins in vivo. CAFs were injected in Matrigel plugs, and matrix remodeling was assessed after 7 days. Control siRNA-transfected CAFs organized collagen into thick bundles that could be visualized by second harmonic imaging and generated elastin fibers that could be detected by their auto-fluorescent properties ([Figure S4](#mmc1){ref-type="supplementary-material"}E). Depletion of either Cdc42EP3 or SEPT2 greatly reduced the formation of thick collagen bundles and elastin fibers in vivo ([Figures 4](#fig4){ref-type="fig"}H and [S4](#mmc1){ref-type="supplementary-material"}F). These data establish that Cdc42EP3 and septins are important for the matrix remodeling and invasion-promoting abilities of CAFs.

CAFs Require Cdc42EP3 and SEPT2 to Promote Angiogenesis and Tumor Growth {#sec2.4}
------------------------------------------------------------------------

We hypothesized that Cdc42EP3 might also be required for other functions of CAFs besides matrix remodeling. In particular, we focused on angiogenesis and tumor growth. qRT-PCR analysis revealed that Cdc42EP3 is required in CAFs for the expression of the key angiogenic factor, *Vegfa*, and several other genes implicated in angiogenesis, including *Vegfc*, *Tgfb1*, and *Tgfb2* ([Figures 5](#fig5){ref-type="fig"}A and [S5](#mmc1){ref-type="supplementary-material"}A). The expression of other factors involved in tumor-stroma crosstalk was not changed following Cdc42EP3 depletion, or in the case of *Vegfb*, *Tgfb3*, and *Ccl2*, modestly increased ([Figure S5](#mmc1){ref-type="supplementary-material"}A). Consistent with the qRT-PCR data, secreted VEGF-A was reduced in CAFs depleted of Cdc42EP3 or SEPT2 ([Figure 5](#fig5){ref-type="fig"}B). We tested the ability of CAFs to drive angiogenesis in vivo. Fibroblasts were injected in Matrigel plugs and the extent of angiogenesis evaluated a week later by endomucin staining. Depletion of Cdc42EP3 or SEPT2 dramatically reduced the angiogenic potential of CAFs in vivo ([Figures 5](#fig5){ref-type="fig"}C and 5D). To test whether the defective matrix remodeling and angiogenic activity of CAFs lacking Cdc42EP3 might influence tumor growth, we established CAFs that were stably depleted for Cdc42EP3 using two different small hairpin RNA (shRNA) sequences ([Figure S5](#mmc1){ref-type="supplementary-material"}B). These CAFs, or the appropriate control CAFs, were then "admixed" with PyMT breast cancer cells and injected orthotopically in immune-competent FVB mice. [Figure 5](#fig5){ref-type="fig"}E shows that tumors containing Cdc42EP3-depleted CAFs were smaller than those tumors with control CAFs. Depletion of Cdc42EP3 in CAFs was also associated with longer survival ([Figure 5](#fig5){ref-type="fig"}F). Histological analysis revealed that αSMA-positive cells were visible in both control and Cdc42EP3-depleted tumors ([Figure 5](#fig5){ref-type="fig"}G). More interestingly, tumors containing Cdc42EP3-depleted CAFs tended to grow as a viable rim surrounding a necrotic core (visible in the lower magnification images in [Figure 5](#fig5){ref-type="fig"}H). This was correlated with reduced blood vessel density in the interior of the tumors, although similar numbers of vessels were present at the margins.

Cdc42EP3 Is Required for Mechano-transduction and YAP Activation {#sec2.5}
----------------------------------------------------------------

Cdc42EP3 and SEPT2 are important for regulation of the actomyosin cytoskeleton and paxillin phosphorylation ([Figures 4](#fig4){ref-type="fig"}A--4C). As these events are responsive to the mechanical properties of the substratum ([@bib7]), we hypothesized that Cdc42EP3 and septins may be required for responses to changes in matrix stiffness. [Figure 6](#fig6){ref-type="fig"}A shows that GFP-SEPT2 forms fibrillar structures within the cell body in CAFs plated on relatively stiff 12 kPa substrates ([Figure 2](#fig2){ref-type="fig"}). However, when the same CAFs are plated on a soft 500 Pa substrate, the distribution of SEPT2 was cortical and fibrillar structures were absent. NFs fail to form SEPT2 fibers in the cell body on both 500 Pa and 12 kPa substrates ([Figure 6](#fig6){ref-type="fig"}A). Further, we noted that the localization of Cdc42EP3 in CAFs changed depending on substrate stiffness: it was diffuse on soft substrates and formed fibrillar structures on stiff matrices ([Figure S6](#mmc1){ref-type="supplementary-material"}). These data demonstrate that septin network organization changes in response to substrate stiffness in CAFs, which express high levels of Cdc42EP3.

To test if Cdc42EP3 was causally implicated in the cytoskeletal changes, we undertook a series of gain- and loss-of-function experiments. We observed that, in contrast to control NFs, NFs overexpressing Cdc42EP3 had increased actin stress fibers and focal adhesions on 12 kPa substrates ([Figure 6](#fig6){ref-type="fig"}B). We additionally investigated the activity of the mechano-responsive transcriptional co-activator YAP ([@bib4], [@bib8]). [Figure 6](#fig6){ref-type="fig"}C shows that Cdc42EP3 overexpression increases the nuclear localization of YAP (quantification in [Figure 6](#fig6){ref-type="fig"}D) and leads to a dose-dependent increase in the mRNA levels of two YAP target genes in NFs, *Ctgf*, and *Ankrd1* ([Figure 6](#fig6){ref-type="fig"}E). CAFs are highly mechano-responsive; they have few stress fibers or focal adhesions and cytoplasmic YAP on 500 Pa matrices, but on 12 kPa matrices, they have nuclear YAP and form extensive stress fibers and paxillin-containing focal adhesions. In the absence of Cdc42EP3 or SEPT2, these mechano-induced changes do not occur ([Figures 6](#fig6){ref-type="fig"}F--6H). We confirmed the reduction in YAP transcriptional activation by measuring *Ankrd1* and *Ctgf* mRNA ([Figures 6](#fig6){ref-type="fig"}I). Together, these data show that Cdc42EP3 and the septin network are required for CAFs to respond to changes in matrix stiffness and activation of the mechano-responsive transcriptional regulator YAP.

Cdc42EP3 Is Induced and Required Early in Fibroblast Activation {#sec2.6}
---------------------------------------------------------------

To explore the chronology of Cdc42EP3 upregulation during the transition from NF to CAF, we evaluated different stages of MMTV-PyMT tumor progression ([@bib4]). Cdc42EP3 expression is already enhanced in hyperplasia-associated fibroblasts (HpAF) and maintained in adenoma-associated fibroblasts (AdAFs) and CAFs ([Figures 7](#fig7){ref-type="fig"}A and 7B). In agreement, increased levels of F-actin and insoluble filamentous septins were also evident in HpAFs and AdAFs ([Figure 7](#fig7){ref-type="fig"}C), as well as Src and paxillin phosphorylation ([Figure 7](#fig7){ref-type="fig"}D). Interestingly, Cdc42EP3 expression and cytoskeletal rearrangements preceded the strong activation of MLC2 in AdAFs and CAFs. Similarly, YAP activation, as determined by the expression of YAP target genes *Cyr61*, *Amotl2*, *Ankrd1*, and *Ctgf*, was only observed in AdAFs and CAFs ([Figure 7](#fig7){ref-type="fig"}E). These data indicate that increased Cdc42EP3 expression is an early event that precedes the highly contractile phenotype and activation of YAP in CAFs.

Many factors, including HGF, TGFβ, and SDF-1α, were able to induce *Cdc42ep3* mRNA in NFs. TGFβ and murine breast cancer cell (4T1) conditioned media (CM) yielded the greatest induction of Cdc42EP3 protein expression ([Figures 7](#fig7){ref-type="fig"}F and [S7](#mmc1){ref-type="supplementary-material"}A). Consistently, treatment of NFs with either TGFβ or 4T1 CM for 48 hr triggered F-actin and septin rearrangements ([Figures S7](#mmc1){ref-type="supplementary-material"}B and S7C), and phosphorylation of MLC2, Src-family kinases, and paxillin ([Figure 7](#fig7){ref-type="fig"}F). Furthermore, depletion of Cdc42EP3 prevented conditioned media from causing changes in the F/G ratios of actin and SEPT2, or in MLC2 and Src activation ([Figures 7](#fig7){ref-type="fig"}G and 7H). Gain-of-function experiments in NFs demonstrated that increasing the levels of Cdc42EP3 expression enhanced the ability of TGFβ and 4T1 CM to induce Src activation and elevated basal pS19-MLC2 levels ([Figures S7](#mmc1){ref-type="supplementary-material"}D and S7E). These changes were associated with increased matrix remodeling after TGFβ- and 4T1 CM treatments ([Figure S7](#mmc1){ref-type="supplementary-material"}F). Further, if contractility was boosted by overexpressing MLC2, as occurs in CAFs ([@bib4]), then a synergistic increase in matrix remodeling was observed in cells with high Cdc42EP3 levels ([Figure S7](#mmc1){ref-type="supplementary-material"}G). These data suggest that elevated expression of Cdc42EP3 sensitizes cells to functional activation by the contractile cytoskeleton. We therefore tested whether elevated Cdc42EP3 levels were required for functional activation of NFs. Depletion of Cdc42EP3 prevented both the activation of collagen gel contraction and cancer cell invasion by NFs in response to cancer cell conditioned media ([Figures 7](#fig7){ref-type="fig"}I and 7J). Together, these data demonstrate that Cdc42EP3 is critical for the functional activation of normal fibroblasts by cancer cells.

Discussion {#sec3}
==========

Here, we describe Cdc42EP3 as a key regulator of the conversion of normal fibroblasts into CAFs. CAFs have enhanced stress fibers, αSMA-positive fibers, and focal adhesions ([@bib4], [@bib21], [@bib30], [@bib35], [@bib39]). We now describe that CAFs are also characterized by increased levels of filamentous septins. These filaments are partly aligned with F-actin fibers in CAFs ([@bib6], [@bib19], [@bib23]). However, septin filaments and actin fibers do not precisely co-localize and time-lapse imaging indicated that the actin and septin networks exhibit different dynamic behaviors. During cytokinesis, the adaptor protein ANLN plays a key role in linking the actin and septin networks ([@bib24]), although recent work suggests that septins alone may be sufficient to drive formation of actin ring-like structures ([@bib26]). Our analyses indicate that Cdc42EP3 may play a similar role during interphase in CAFs. Cdc42EP3 can bind both actin and septins and localizes between F-actin fibers and SEPT2 filaments. Dynamic and mutational analysis suggests that Cdc42EP3 can bind to septins independent of binding to F-actin. We propose that dynamic septin filaments associated with Cdc42EP3 are then able to interact with actin filaments. Cdc42EP3 overexpression in NFs induces F-actin and septin polymerization, suggesting that connectivity between the two networks stabilizes them both. Indeed, the "cross brace" pattern of SEPT2 and Cdc42EP3 localization between stress fibers could provide mechanical support for the contractile actin cytoskeleton. This may allow for increased isometric tension in the F-actin network. These cytoskeletal changes are significant for both remodeling of the extracellular environment within tumors and cell signaling within CAFs, such as YAP activation. In the absence of Cdc42EP3, CAFs are unable to effectively remodel the ECM, leading to a reduction in matrix stiffness and less cancer cell invasion. In vivo analysis confirms the importance of Cdc42EP3 for ECM remodeling, as measured by collagen's second harmonic generation and elastin autofluorescence, and reveals that Cdc42EP3 is required for CAFs to promote angiogenesis. Similar loss-of-function phenotypes are observed when the septin network is depleted. Further, in vivo "admix" experiments with breast cancer cells demonstrate that Cdc42EP3 is required for efficient tumor growth. Our data establish that connectivity between the actin and septin networks is crucial for the function of CAFs from breast and squamous cell carcinoma. It will be interesting to determine the role of actin and septin networks in CAFs from pancreatic cancer, which can have both tumor-promoting and suppressive effects ([@bib31], [@bib34]).

Intriguingly, Cdc42EP3 upregulation precedes the emergence of highly contractile CAFs and YAP activation. Cdc42EP3 expression is already elevated in fibroblasts at the hyperplasia stage. Multiple signaling pathways converge upon *Cdc42EP3* promoter ([@bib9], [@bib14], [@bib27], [@bib41]). Therefore, Cdc42EP3 expression may be highly responsive to the small perturbations in tissue homeostasis that are likely to occur in hyperplastic tissue. However, this raises the question of why its expression does not lead to fully activated fibroblasts early in disease progression. It has been argued that both chemical and mechanical stimulation are needed for the acquisition of pathological active fibroblasts ([@bib16]). We propose that Cdc42EP3 is located at a node linking both activating processes. Soluble factors---either from hyperplastic epithelia or leukocytes infiltrating the pre-malignant tissue---could induce Cdc42EP3 expression in normal fibroblasts. This would sensitize the cells to mechanical cues, but in the absence of changes to the physical environment it would not trigger the activation of mechano-responsive signaling pathways. This is consistent with the small effect of Cdc42EP3 overexpression alone on NF function and the synergy observed when Cdc42EP3 and MLC2 are both overexpressed ([Figure S7](#mmc1){ref-type="supplementary-material"}G). Further, when CAFs are grown on low stiffness gels (500 Pa, slightly above normal mouse mammary tissue stiffness) they do not form stress fibers or large focal adhesions and have only modest levels of nuclear YAP ([Figures 6](#fig6){ref-type="fig"}E--6G). Full activation of the highly contractile CAF phenotype and YAP activation would require concomitant stiffening of the ECM. The changes in the physical properties of the ECM are likely to happen with slow kinetics and may not coincide with the faster upregulation of Cdc42EP3 induced by soluble factors. This would explain why full pathological activation of fibroblasts does not occur early in disease progression ([@bib4]).

To conclude, we demonstrate a key role for coordination between the actin and the septin networks in CAFs. This is required for force-mediated matrix remodeling, promoting cancer cell invasion, angiogenesis, and tumor growth. Further, if coordination of F-actin and septin networks is prevented, then fibroblasts are unable to activate mechano-sensing signaling pathways, including paxillin phosphorylation, Src, and YAP. The elevated expression of Cdc42EP3 in the stroma of pre-malignant lesions enables the subsequent activation of these pathways and the emergence of fully activated CAFs.

Experimental Procedures {#sec4}
=======================

cDNA, siRNA, and Reagents {#sec4.1}
-------------------------

Murine Cdc42EP3 cDNA was acquired from Thermo Scientific (pCMV-Sport 6-Cdc42EP3) and subcloned into pEGFP.C1 and PKR5.1-Flag. pEGFP-Cdc42EP3 was used to generate Cdc42EP3(IS-AA), Cdc42EP3(GPS-AAA), and Cdc42EP3(KLP-AAA) and was subcloned in pCSII-IRES to generate stable cells lines. pEGFP-MLC2 was a gift from Michael Olson (Beatson Institute). SEPT2-GFP and SEPT2-Cherry were a gift from Elias Spiliotis (Drexel University). MARS-Lifeact was a gift from Michael Sixt (Institute of Science and Technology). siRNA were purchased from Dharmacon and are listed in the [Table S1](#mmc1){ref-type="supplementary-material"}. shRNA-targeting murine Cdc42EP3 were purchased from Thermo Scientific (pGIPZ backbone). The following growth factors and drugs were used: TGFβ (Peprotech), LPA (Sigma), HGF (Peprotech), and SDF-1 (Peprotech). Breast cancer cell conditioned medium was harvested from 4T1 cells in DMEM 1% fetal bovine serum (FBS) for 48 hr and filtered through a 0.22-μm filter. Fibroblasts were transfected with 100 nM siRNA using DharmaFECT 1 (Dharmacon) and Lipofectamine (Life Technologies) for plasmids.

Cell Lines {#sec4.2}
----------

Fibroblasts from normal mammary glands (NFs), hyperplastic mammary tissue (HpAFs), mammary adenoma/early carcinoma tissue (AdAFs), and mammary carcinoma (CAFs) have been previously described ([@bib4]). Fibroblasts were cultured in DMEM (Invitrogen), 10% FBS, and 1% insulin-selenium-transferrin (ITS). 4T1 murine breast cancer cells were used for the organotypic invasion assays and to generate breast cancer cell conditioned media. SCC12 human squamous cell carcinoma cells were used for organoytpic invasion assays of HN-CAF and Cer-CAF. MMTV-PyMT TS1 murine breast cancer cells were used to generate orthotopic tumors in syngeneic FVB/n mice. Cell lines stably expressing Cdc42EP3-GFP, shRNA control, and shRNA-targeting murine Cdc42EP3 were generated by lentiviral infection. NF\#1 stably expressing Cdc42EP3-GFP were sorted into low (NF\#1-Cdc42EP3-GFP^low^) and high (NF\#1-Cdc42EP3-GFP^high^) expression by fluorescence-activated cell sorting.

ECM Remodeling and Invasion Assays {#sec4.3}
----------------------------------

ECM-remodeling (contraction) assays and human SCC CAF and mouse mammary CAFs organotypic culture systems were as previously described ([@bib4]). Details are provided in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Screening {#sec4.4}
---------

Smart-pool siRNA were transiently transfected into two individual CAF lines (CAF\#1 and CAF\#2). The functional role of each gene was assessed using collagen gel contraction assays and 4T1 breast cancer cell organotypic invasion assays. Each experimental point was normalized against the control siRNA for that experiment.

Biophysical Methods {#sec4.5}
-------------------

AFM was performed as described ([@bib4]), and details are provided in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}. Polyacrylamide gels of defined elastic moduli were made as described ([@bib40]).

Immunofluorescence {#sec4.6}
------------------

Cells were fixed in 4% paraformaldehyde, except for the analysis of endogenous septins when cells were fixed in ice-cold methanol for 10 min. Cells were permeabilized by incubation in PBS 0.5% NP-40 (Sigma) at 4°C for 20 min (twice), PBS 0.3% Triton 100 (Sigma) at room temperature (RT) for 20 min, and PBS 0.1% Triton 100 at room temperature (RT) for 15 min (twice). Samples were blocked in 4% BSA PBS 0.05% Tween20 (Sigma) and incubated with primary antibody in blocking solution overnight at 4°C. After three PBS washes, secondary antibody in blocking solution was added for 3 hr. After three PBS washes, samples were mounted and analyzed using an inverted Zeiss LSM780/Leica SP8. For analysis of fibronectin production, cells were kept in 1% FBS for 24 hr before fixing and were permeabilized for only 5 min in 0.1% Triton 100 at RT during the staining procedure to reduce detection of intracellular protein. Antibody description and working dilutions can be found in [Table S2](#mmc1){ref-type="supplementary-material"}. Time-lapse microscopy was performed using a Zeiss LSM780 with cells in CO~2~-independent media (GIBCO) containing 10% FBS. The details of the imaging analysis methods are provided in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Structured Illumination Microscopy {#sec4.7}
----------------------------------

Cells were processed for immunostaining as usual and mounted in a 1:1 mixture of glycerol and MOWIOL. Imaging was performed using a Zeiss ELYRA PS1 and data processed using the SIM tools in the Zen 2011 software. Channel alignment was performed with 0.1-μm TetraSpeck fluorescent microspheres (Life Technologies).

Collagenase Activity Measurements {#sec4.8}
---------------------------------

A thin layer of collagen gel (4.6 mg/ml) containing 50 μg/ml of ^DQ^FITC-Collagen I from bovine skin (Life Technologies) and 10% FBS was generated. After 1 hr, fibroblasts were seeded on top. After 48 hr, samples were fixed in 4% paraformaldehyde for 1 hr and stained for F-actin. A fluorescein isothiocyanate signal generated by cleaved collagen and F-actin staining was detected using an inverted Leica SP8 microscope.

F-G Actin and Septin Fractionation {#sec4.9}
----------------------------------

We determined the relative proportions of filamentous and globular actin and septins by sedimentation, followed by quantitative analysis by SDS-PAGE. Cells were lysed in warm F-actin stabilization buffer (PIPES 100 mM \[pH 6.9\], 5 mM MgCl~2~, 1 mM EGTA, 30% glycerol, 0.1% Triton X-100, 0.1% NP-40, 0.1% Tween-20, 0.15% 2-mercaptoethanol, 1 mM ATP, and complete EDTA-free cocktail) and homogenized using a 25G gauge. Lysates were incubated for 10 min at 37°C, and cellular debris was removed by centrifugation at room temperature. Supernatants were then subjected to ultracentrifugation at 37°C (1 hr at 100,000 *g*). Supernatants containing the globular cytosolic fraction (G fraction) were removed. Using a similar volume of 10 mM CaCl~2~ 10 μM Cytochalasin D, the pellet containing the fibrillar fraction (F fraction) was dissolved for 1 hr in ice. Both G and F fractions were mixed with 5× sample buffer before western blot analysis. Antibody description and working dilutions can be found in [Table S2](#mmc1){ref-type="supplementary-material"}.

In Vitro F-actin Binding Assay {#sec4.10}
------------------------------

Human platelet actin (Cytoskeleton, Actin Binding Protein Biochem Kit \#BK013) in general actin buffer (5 mM Tris-HCl \[pH 8.0\] and 0.2 mM CaCl~2~, supplemented with 0.2 mM ATP) was polymerized using actin polymerization buffer (50 mM KCl, 2 mM MgCl~2~, and 1 mM ATP) at 24°C for 1 hr. 0.3 μM GST-Cdc42EP3 (Abcam, ab161060) and recombinant 0.3 μM glutathione S-transferase (GST) (Sigma-Aldrich; SRP5348) were incubated with 20 μM F-actin for 1 hr at 24°C and centrifuged at 150,000 *g* for 90 min at 24°C. Equal volumes of the supernatant and pellet fractions were resolved using a 4%--12% SDS-PAGE gel, stained with InstantBlue (Expedeon) for actin staining, and further processed by western blotting (for GST and GST-Cdc42EP3) analysis.

Immunoprecipitation {#sec4.11}
-------------------

GFP-Cdc42EP3 immunoprecipitations were performed in HEK293 cells. Cells were transiently transfected and subsequently lysed in NP-40 lysis buffer (50 mM Tris \[pH 7.4\], 150 mM NaCl, 1 mM EDTA, and 1% NP-40). Lysates were cleared by centrifugation and supernatants were further cleared by pre-incubating with 25 μl of G-sepharose. Cleared supernatants were then mixed with 2 μg of anti-GFP antibody plus 25 μl of G-sepharose and incubated for 2 hr at 4°C. Immunoprecipitations were then washed four times with NP-40 washing buffer (50 mM Tris \[pH 7.4\], 150 mM NaCl, 1 mM EDTA, 1% NP40, and 0.25% gelatin) before adding sample buffer. Antibody details can be found in [Table S2](#mmc1){ref-type="supplementary-material"}.

Western Blotting {#sec4.18}
----------------

Unless stated otherwise, all protein lysates were obtained from cells seeded on top of a thin layer of a mixture of collagen I:Matrigel matrices. Western blot exposures within the dynamic range were obtained on film and quantified by densitometry with the program NIH Image 1.60, except for [Figures S1](#mmc1){ref-type="supplementary-material"}B, [S3](#mmc1){ref-type="supplementary-material"}I, and [S7](#mmc1){ref-type="supplementary-material"}D, which were generated with the Azure c300 scanner. Antibody details can be found in [Table S2](#mmc1){ref-type="supplementary-material"}.

Detection of VEGF-A in Conditioned Media {#sec4.12}
----------------------------------------

ELISA was used to assess the levels of secreted murine VEGF-A in accordance with the manufacturers' instructions (R&D; Mouse VEGF DY493-05). 10^5^ cells were seeded on 12-well plates, and 24 hr later cells were washed and 0.6 ml of DMEM supplemented with 0.5% FBS added to each well. Medium was collected and assayed after 24 hr of conditioning.

In Vivo Matrigel Plugs {#sec4.13}
----------------------

2 × 10^6^ fibroblasts were suspended in 100 μl of PBS and mixed in 300 μl of Matrigel. Then 300 μl of the mixture were injected subcutaneously on the mammary fat pad of a 12-week-old FVB/n female. After 7 days, the plugs were fixed in 4% paraformaldehyde. Blood vessel density was calculated by normalizing the area of endomucin staining to the area of vimentin staining of all the slices processed. Antibody details are in [Table S2](#mmc1){ref-type="supplementary-material"}. Collagen second harmonic generation (SHG) and elastin signal were acquired by excitation of sections with an 880-nm pulsed Ti-Sapphire laser and emitted light acquired at 440 nm (SHG) and 535 nm (Elastin) using a Leica SP8 microscope.

Generation of Syngeneic Orthotopic Tumors {#sec4.14}
-----------------------------------------

MMTV-PyMT TS1 murine breast cancer cells were used to generate orthotopic tumors in wild-type FBV/n mice. 10^6^ TS1 cells and 3 × 10^6^ CAFs (shRNA control, shRNA-Cdc42EP3\#1, or shRNA-Cdc42EP3\#2) were suspended in 100 μl of PBS:Matrigel (50:50) and injected orthotopically into the mammary fat pad of 6- to 8-week-old females. To calculate tumor volume, the formula V = (length × width^2^)/2 was used. Tumors were fixed in 4% paraformaldehyde for histological analysis. Antibody description and working dilutions can be found in [Table S2](#mmc1){ref-type="supplementary-material"}. Mice were kept in accordance with UK regulations under project license PPL 70/ 8380.

mRNA Analysis {#sec4.15}
-------------

RNA was isolated using an RNeasy Kit (QIAGEN). Reverse transcription was performed using Precision nanoScript 2 Reverse-Transcription Kit (PrimerDesign), and qPCR was performed using PrecisionPLUS 2x qPCR MasterMix with ROX and SybrGreen (PrimerDesign). Oligonucleotides for qRT-PCR are described in the [Table S3](#mmc1){ref-type="supplementary-material"}. Expression levels are normalized to the expression of *Gapdh*, *Rplp1*, or *Lamc2*. Gene-set enrichment analyses (GSEA) details are provided in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Analysis of Expression in Clinical Samples {#sec4.16}
------------------------------------------

mRNA levels of BORG family members in the stromal compartment of human tumors were obtained from GSE9014 (Finak breast dataset) and GSE8977 (Karnoub breast dataset) ([@bib11], [@bib22]). Probes on the Finak dataset were A_23_P166453 (CDC42EP1), A_23_P1602 (CDC42EP2), A_23_P209636 (CDC42EP3), A_23_P66891 (CDC42EP4), and A_24_P44916 (CDC42EP5). Probes on the Karnoub dataset were 204693_at (CDC42EP1), 214014_at (CDC42EP2), 225685_at (CDC42EP3), 218062_x\_at (CDC42EP4), and 227850_x\_at (CDC42EP5).

Statistical Analyses {#sec4.17}
--------------------

Paired or unpaired two-tailed Student's t test, Mann-Whitney's test, and one-way ANOVA with Tukey post-test (for multiple comparisons) were performed using GraphPad Prism (GraphPad Software). Unless stated otherwise, mean values and SEM are shown. Survival curves were estimated based on the Kaplan-Meier method and compared using a log rank test. p values of less than 0.05 are considered statistically significant: ^∗^, p \< 0.05; ^∗∗^, p \< 0.01; ^∗∗∗^, p \< 0.001; ^∗∗∗∗^, p \< 0.0001; ns, non-significant.
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![Identification of Cdc42EP3 as a Key Regulator of CAF Functions\
(A) The left panels show images of F-actin (red) and paxillin (green) staining in NF\#1, NF\#2, CAF\#1, and CAF\#2. The right panels show images of F-actin (red) and pS19-MLC2 (green) staining in NF\#2 and CAF\#2. Scale bars represent 20 μm.\
(B) Histograms show focal adhesion (FA) area normalized to total cell area (left graph), an F-actin stress fibers (SF) component (middle graph), and pMLC2 associated to SF (right graph) of NF and CAF cells. Bars represent mean ± SEM. FA measurements, n = 16; measurements were performed on NF\#1 and NF\#2 (NF) and CAF\#1 and CAF\#2 (CAF). F-actin and pMLC2 measurements, n = 12 for NF and n = 15 for CAF; measurements were performed on NF\#1 and CAF\#1.\
(C) Western blot showing pY118-paxillin (pPax), pY416-Src (pSFK), and pS19-MLC2 (pMLC2) in three sets of NF and CAFs (NF\#1, NF\#2, NF\#3, CAF\#1, CAF\#2, and CAF\#3). A tubulin blot is also shown.\
(D) RNAi-based loss-of-function screen in CAFs. The indicated genes (left column) were knocked down by smart-pool siRNA, and the functional outcomes were evaluated in gel contraction (CAF\#1) and organotypic invasion assays (CAF\#1 and CAF\#2). The values indicate the fold activity normalized to control siRNA-transfected CAFs for each experiment (red is low; blue is high). Genes are ranked on their average score (right column).\
(E) Western blot and quantification showing Cdc42EP3 and tubulin expression in CAF\#1 after transfection with control and three different Cdc42EP3 siRNA (siCEP3). Bars represent mean ± SEM (n = 4).\
(F) Histogram shows gel contraction by CAF\#1 following transfection with control or three different Cdc42EP3 siRNA (siCEP3). Bars represent mean ± SEM (n = 3).\
(G) Images and quantification of 4T1 invasion when co-cultured with CAF\#1 transfected with control or three single Cdc42EP3 siRNA (siCEP3). Bars represent mean ± SEM (n = 14 organotypic assays assessed over three experiments). Scale bar, 50 μm.\
(H) Western blots showing Cdc42EP3, Cdc42EP5, and 14-3-3 levels in three sets of NF and CAFs (NF\#1--3, CAF\#1--3). The chart shows Cdc42EP3 and Cdc42EP5 fold expression (normalized to 14-3-3).\
See also [Figure S1](#mmc1){ref-type="supplementary-material"}.](gr1){#fig1}

![CAFs Have Enhanced Actin and Septin Cytoskeletal Networks\
(A) Panels show SEPT2 (green) and SEPT7 (red) staining in NF\#1 and CAF\#1. Zoom areas are shown for each channel and cell type. Scale bars represent 10 μm. See [Figure S2](#mmc1){ref-type="supplementary-material"}A for quantification.\
(B) Western blot showing the fibrillar (F) and soluble (G) content of actin, SEPT2, and SEPT7 in two NF lines (NF\#1-2) and four CAF lines (CAF\#1-4). A 14-3-3 blot is also shown as an internal cytosolic control. See [Figure S2](#mmc1){ref-type="supplementary-material"}C for quantification.\
(C) Representative SIM images of SEPT2-GFP (yellow) and F-actin (magenta) staining in CAF\#1. White arrows indicate SEPT2-GFP filaments along actin stress fibers. The green arrows indicate SEPT2-GFP filaments connecting nearby stress fibers. Scale bars represent 1 μm.\
(D) Panels show actin (red), endogenous Cdc42EP3 (green), and DAPI (blue) staining of CAF\#1. Cells were fixed using methanol. Zoom-up area showing actin and Cdc42EP3 is shown. Bar represents 10 μm.\
(E) Representative SIM image of F-actin (magenta) and Cdc42EP3-GFP (green) in CAF\#1. Bar represents 1 μm. White arrows indicate Cdc42EP3-GFP filaments associated to actin stress fibers. Yellow arrows indicate Cdc42EP3-GFP wavy filaments that do not co-align with F-actin.\
(F) Single channel and merged confocal images of SEPT2-Cherry (red), Cdc42EP3-GFP (green), and F-actin (blue) in CAF\#1. White arrows indicate SEPT2- and Cdc42EP3-containing filaments that co-align with F-actin. Yellow arrows indicate SEPT2- and Cdc42EP3-containing filaments that interconnect F-actin cables. Scale bar represents 1 μm.\
(G) Representative single channel and merged SIM images of SEPT2-Cherry (red), Cdc42EP3-GFP (green), and F-actin (blue) in CAF\#1. Scale bars represent 1 μm.\
See also [Figure S2](#mmc1){ref-type="supplementary-material"} and [Movies S1](#mmc2){ref-type="supplementary-material"}, [S2](#mmc3){ref-type="supplementary-material"}, [S3](#mmc4){ref-type="supplementary-material"}, and [S4](#mmc5){ref-type="supplementary-material"}.](gr2){#fig2}

![Cdc42EP3 Regulates the Actin and Septin Fibrillar Networks\
(A) Images show pS19-MLC2 (green), F-actin (red), and DAPI (blue) staining of CAF\#1 following control and Cdc42EP3 siRNA (siCEP3, smart pool). The grayscale panels show individual channel magnifications of the indicated areas. Scale bars, 25 μm. See [Figure S3](#mmc1){ref-type="supplementary-material"}A for quantification.\
(B) Images show SEPT2 (green), SEPT7 (red), and DAPI (blue) staining of CAF\#1 following control and Cdc42EP3 siRNA (siCEP3, smart pool). The grayscale panels show individual channel magnifications of the indicated areas. Scale bars, 25 μm. See [Figure S3](#mmc1){ref-type="supplementary-material"}B for quantification.\
(C) Western blot showing the fibrillar (F) and soluble (G) content of actin, SEPT2, and SEPT7 in CAF\#1 following control and Cdc42EP3 siRNA (siCEP3, smart pool). A 14-3-3 blot is also shown as a cytosolic control. See [Figure S3](#mmc1){ref-type="supplementary-material"}D for quantification.\
(D) Box and whisker plot showing the Young's elastic modulus of CAF\#1 cells with control and Cdc42EP3 siRNA (siCEP3, smart pool). The central box represents the lower to upper quartiles; the middle line represents the mean. The horizontal line extends from the minimum to the maximum value (n = 61 single measurements for siCtr; n = 53 single measurements for siCEP3).\
(E) Western blot showing the fibrillar (F) and soluble (G) content of actin, SEPT2, and SEPT7 in empty vector (−) and Flag-Cdc42EP3 (Flag-CEP3)-transfected NF\#1. The histogram shows the F/G ratios of actin, SEPT2, and SEPT7. Bars represent mean ± SEM (n = 3).\
(F) Top left inserts show GFP (green), SEPT2 (blue), and SEPT7 (red) staining of NF\#1 following transfection with GFP or GFP-tagged Cdc42EP3 (CEP3) proteins. The grayscale panels show individual channel magnifications of perinuclear areas. Scale bars, 20 μm.\
(G) Top left inserts show GFP (green) and actin (red) staining of NF\#1 following transfection with GFP or GFP-tagged Cdc42EP3 (CEP3) proteins. The grayscale panels show individual channel magnifications of perinuclear areas. Scale bars, 20 μm.\
(H) Histograms show fibrillar SEPT2&7 area (top) and F-actin stress fiber (SF) component (bottom) for the indicated experimental points. Bars represent mean ± SEM (5 \< n \< 10 single-cell measurements).\
See also [Figure S3](#mmc1){ref-type="supplementary-material"}.](gr3){#fig3}

![The Septin Cytoskeleton Is Required for CAF Functions\
(A) Images showing F-actin (red), pS19-MLC2 (green), and DAPI (blue) staining of CAF\#1 following control, Cdc42EP3, SEPT2, and DIAPH1&3 siRNA transfection (smart pools). Scale bars, 20 μm. Histograms show an F-actin stress fiber (SF) component and pMLC2 associated to SF for the indicated points. Bars represent mean ± SEM (12 \< n \< 15).\
(B) Images show F-actin (red), paxillin (green), and DAPI (blue) staining of CAF\#1 following with control, Cdc42EP3, SEPT2, and DIAPH1&3 siRNA transfection (smart pools). Scale bars, 20 μm. The histogram shows the focal adhesion (FA) area normalized to total cell area in single cells. Bars represent mean ± SEM (10 \< n \< 12).\
(C) Western blot showing phosphorylated levels of pY118-paxillin (pPax), pY416-Src (pSFK), and pS19-MLC2 (pMLC2) in CAF\#1 following transfection with control, Cdc42EP3 (CEP3), DIAPH1&3, and SEPT2 siRNA (smart pools). Cdc42EP3 and tubulin blots are also shown.\
(D) Western blots showing fibrillar (F) and soluble (G) actin and SEPT2 in CAF\#1 following control, Cdc42EP3 (CEP3), SEPT2, SEPT7, and DIAPH1&3 siRNA (smart pools). The histogram shows the F/G ratios of actin and SEPT2. Bars represent mean ± SEM (n = 5).\
(E) Histogram shows gel contraction by CAF\#1 following control, SEPT2, and SEPT7 siRNA (smart pools). Bars represent mean ± SEM (n = 8).\
(F) Histogram shows the elastic modulus of matrices remodeled by NF\#1 or CAF\#1 following control, Cdc42EP3, or SEPT2 siRNA (smart pools). Bars indicate mean ± SD (n = 167 single measurements for NF-siCtr; n = 142 for CAF-siCtr; n = 173 for CAF-siCEP3; n = 51 for siSEPT2).\
(G) Quantification of 4T1 invasion when co-cultured with CAF\#1 transfected with control or SEPT2 and SEPT7 siRNA (smart pool). Bars represent mean ± SEM (n = 9 organotypic assays assessed over two experiments).\
(H) Charts show second harmonic generation (SHG) of collagen fibers and elastin-positive areas in the CAF\#1 matrix plugs transfected with control, Cdc42EP3 (CEP3), and SEPT2 siRNA. Line and error bars indicate mean ± SEM (n = 4 plugs from different mice).\
See also [Figure S4](#mmc1){ref-type="supplementary-material"}.](gr4){#fig4}

![Cdc42EP3 Is Required for the Pro-tumorigenic Activity of CAFs In Vivo\
(A) mRNA levels of angiogenic factors *Vegfa*, *Vegfc*, and *Tgfb1* in NF\#1 and CAF\#1 following transfection with control and Cdc42EP3 siRNA (CEP3, smart pool). Bars represent mean ± SEM (n = 12).\
(B) Secreted levels of VEGF-A on CAF\#1 following transfection with control, Cdc42EP3 (CEP3), SEPT2, or SEPT7 siRNA (smart pool). Bars represent mean ± SEM (n = 6).\
(C) Representative images showing endomucin and vimentin staining of matrix plugs with NF\#1 or CAF\#1 transfected with control, Cdc42EP3 (CEP3), and SEPT2 siRNA (smart pools) and injected sub-cut in mice. Scale bars, 100 μm.\
(D) Chart shows quantification of endomucin staining relative to fibroblast number (vimentin staining). Line and error bars indicate mean ± SEM (n = 7, except for CAF\#1-siCtr that n = 9 and CAF\#1-siSEPT2 that n = 5; each experimental point is an individual plug from a different mouse).\
(E) Box and whisker plot showing volumes of orthotopic tumors generated by co-injection of TS1 murine MMTV-PyMT breast cancer cells with CAF\#3 stably expressing control or two different shRNA targeting Cdc42EP3. The central box represents the lower to upper quartiles; the middle line represents the mean; and the horizontal line extends from the minimum to the maximum value (n = 7, except for CAF-shCtr that n = 6). Tumors were measured at day 24 post-injection.\
(F) Survival curves for orthotopic tumors generated by co-injection of TS1 murine MMTV-PyMT breast cancer cells with CAF\#3 stably expressing control or two different shRNA targeting Cdc42EP3. The survival curve represents the percentage of animals alive at the indicated time point after injection. Survival curves were estimated by the Kaplan-Meier method and compared among subsets using the log rank test.\
(G) Representative images of orthotopic tumors generated by co-injection of TS1 murine MMTV-PyMT breast cancer cells with CAF\#3 stably expressing control or two different shRNA targeting Cdc42EP3 and stained for H&E or αSMA. Scale bar, 500 μm.\
(H) Representative images of orthotopic tumors generated by co-injection of TS1 murine MMTV-PyMT breast cancer cells with CAF\#3 stably expressing control or two different shRNA targeting Cdc42EP3 and stained for H&E or endomucin. Scale bar, 200 μm.\
See also [Figure S5](#mmc1){ref-type="supplementary-material"}.](gr5){#fig5}

![Cdc42EP3 Is Required for Mechano-sensing\
(A) Images show single and merged channels of SEPT2-GFP (yellow) and F-actin (magenta) staining of NF\#1 and CAF\#1 when seeded on soft (∼500 Pa) and stiff (∼12 kPa) matrices. Scale bar represents 10 μm.\
(B) Images show F-actin (red) and pY118-Paxillin (pPax) staining of NF\#1 when seeded on stiff (∼12 kPa) matrices following transfection with GFP-CAAX and Cdc42EP3-GFP. Inserts show GFP signal (grayscale). Scale bar represents 10 μm.\
(C) Images show GFP (green) and YAP (red) staining of NF\#1 when seeded stiff (∼12 kPa) matrices following transfection with Cdc42EP3-GFP. Scale bar represents 10 μm.\
(D) Histogram shows nuclear YAP fluorescent intensity/cytoplasmic YAP fluorescent intensity of NF\#1 when seeded on soft (∼500 Pa) and stiff (∼12 kPa) matrices following transfection with GFP-CAAX or Cdc42EP3-GFP. The mean and 95% confidence interval are shown (23 \< n \< 80 cells).\
(E) Fold mRNA levels of YAP target genes *Ankrd1* and *Ctgf* in stable cell lines NF\#1 null, NF\#1-Cdc42EP3^low^, and NF\#1-Cdc42EP3^high^ maintained in 1% FBS for 6 hr. Bars represent mean ± SEM (n = 5).\
(F) Images show F-actin (red) and paxillin (green) staining of CAF\#1 when seeded on soft (∼500 Pa) and stiff (∼12 kPa) matrices following transfection with control, Cdc42EP3, or SEPT2 siRNA (smart pools). Scale bar represents 10 μm.\
(G) Images show F-actin (red) and YAP (green) staining of CAF\#1 when seeded on soft (∼500 Pa) and stiff (∼12 kPa) matrices following transfection with control, Cdc42EP3, or SEPT2 siRNA (smart pools). Scale bar is 10 μm.\
(H) Histogram shows nuclear YAP fluorescent intensity/cytoplasmic YAP fluorescent intensity for the indicated conditions. The mean and 95% confidence interval are shown (23 \< n \< 80 cells).\
(I) Relative mRNA levels of YAP target genes *Ankrd1* and *Ctgf* in NF\#1 and CAF\#1 following transfection with control, Cdc42EP3 (CEP3), and YAP siRNA (smart pools). Bars represent mean ± SEM (n = 6).\
See also [Figure S6](#mmc1){ref-type="supplementary-material"}.](gr6){#fig6}

![Cdc42EP3 Is Induced and Required Early in Fibroblast Activation\
(A) Western blots of Cdc42EP3 in fibroblasts isolated from different disease stages (NF, HpAF, AdAF, and CAF).\
(B) Relative levels of *Cdc42ep3* mRNA in fibroblasts from different disease stages. Bars indicate mean ± SEM (n = 4).\
(C) Western blot showing the fibrillar (F) and soluble (G) actin, SEPT2, and SEPT7 in fibroblasts from different disease stages. A 14-3-3 blot is also shown as an internal cytosolic control.\
(D) Western blots showing pY118-paxillin (pPax), pY416-Src (pSFK), and pS19-MLC2 (pMLC2) and tubulin levels in fibroblasts isolated from different disease stages.\
(E) GSEA-derived heatmap showing the relative levels of mRNA expression of YAP target genes (*Cyr61*, *Amotl2*, *Ankrd1*, and *Ctgf*) in fibroblasts isolated from different disease stages on duplicate. Colors range from dark red to dark blue, representing, respectively, the highest and lowest normalized expression of the gene.\
(F) Western blots showing pY118-paxillin (pPax), pY416-Src (pSFK), and pS19-MLC2 (pMLC2) in NF\#1 subjected to 1% FBS (NM), TGFβ (2 ng/ml), and breast cancer cell conditioned media (CM) for 48 hr. Cdc42EP3 and actin blots are also shown.\
(G) Western blots of fibrillar (F) and soluble (G) fractions of actin and SEPT2 in NF\#1 subjected to 1% FBS (NM) or breast cancer cell conditioned media (CM) following transfection with control and two single Cdc42EP3 (CEP3) siRNA.\
(H) Western blots showing tubulin and pY118-paxillin (pPax), pY416-Src (pSFK), and pS19-MLC2 (pMLC2) in NF\#1 subjected to 1% FBS (NM) or breast cancer cell conditioned media (CM) following transfection with control and two single Cdc42EP3 (CEP3) siRNA.\
(I) Histogram showing gel contraction of NF\#1 subjected to normal media (NM) or breast cancer cell conditioned media (CM) following transfection with control and two single Cdc42EP3 (CEP3) siRNA. Bars represent mean ± SEM (n = 5).\
(J) Histogram showing organotypic cancer cell invasion of NF\#1 subjected to normal media (NM) or breast cancer cell conditioned media (CM) following transfection with control two single Cdc42EP3 (CEP3) siRNA. Bars represent mean ± SEM (n = 5).\
See also [Figure S7](#mmc1){ref-type="supplementary-material"}.](gr7){#fig7}
